| Hans-Günter Meyer-Thompson | international
Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review.
Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic review.
Adams A, Blawatt S, MacDonald S, Finnick R, Lajeunesse J, Harrison S, Byres D, Schechter MT, Oviedo-Joekes E.
Int J Drug Policy. 2023 May 8;117:104058. doi: 10.1016/j.drugpo.2023.104058. Epub ahead of print. PMID: 37182352; PMCID: PMC10165059.